Showing 3051-3060 of 20899 results for "".
- Distinct Melanoma Tumor Characteristics Identified in Pediatric, Adolescent and Young Adult Patientshttps://reachmd.com/news/distinct-melanoma-tumor-characteristics-identified-in-pediatric-adolescent-and-young-adult-patients/2468700/Melanoma, though rare in younger populations, presents distinct characteristics in pediatric and adolescent and young adult (AYA) patients, according to a recent study in the Journal of the American Academy of Dermatology. Researchers foundnotable differences in tumor incidence, location
- J&J Seeks FDA Approval for Pediatric Tremfya Indicationshttps://reachmd.com/news/jj-seeks-fda-approval-pediatric-tremfya-indications/2468706/Johnson & Johnson (J&J) has submitted supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Tremfya (guselkumab), seeking approval for pediatric indications. Tremfya, the first approved monoclonal antibody IL-23 inhibitor that select
- Immune Checkpoint Inhibitors Linked to Increased Psoriasis Riskhttps://reachmd.com/news/immune-checkpoint-inhibitors-linked-to-increased-psoriasis-risk/2468674/Patients treated with immune checkpoint inhibitors (ICIs) may face a significantly increased risk of developing psoriasis compared to those receiving other cancer therapies, according to a new study published in JAMA Dermatology. The findings underscore an important consideration for cli
- Standardized Autism Screening During Toddler Well Visits Identifies More Children Earlier, Including Those With Subtle Symptomshttps://reachmd.com/news/standardized-autism-screening-during-toddler-well-visits-identifies-more-children-earlier-including-those-with-subtle-symptoms/2468672/A recent study from Drexel University’s A.J. Drexel Autism Institute has revealed that standardized autism screening during pediatric well-child visits leads to earlier identification of children at high likelihood for autism, including those with milder or less obvious symptoms. Published in the
- Cardiac Arrest Survival Improved Since COVID-19 Pandemic Waned, Still Lower Than Prior Yearshttps://reachmd.com/news/cardiac-arrest-survival-improved-since-covid-19-pandemic-waned-still-lower-than-prior-years/2468649/This news release contains updated information and data not included in the abstract. Research Highlights: U.S. survival rates from out-of-hospital cardiac arrests fell significantly at th
- Atopic Dermatitis Insights from SDPA: Innovations and Barriers in Carehttps://reachmd.com/news/atopic-dermatitis-insights-from-sdpa-innovations-and-barriers-in-care/2468680/At the SDPA’s 22nd Annual Fall Dermatology Conference, Matthew Zirwas, MD, delivered an engaging lecture titled “Managing Atopic Dermatitis: Innovations, Challenges, and Care Strategies.” Dr. Zirwas shared critical insights into the evolving understanding of atopic dermatitis (AD), with a focus o
- Can Fenugreek Seeds Improve Skin Clarity? What the Evidence Really Showshttps://reachmd.com/news/can-fenugreek-seeds-improve-skin-clarity-what-the-evidence-really-shows/2468673/Can Fenugreek Seeds Improve Skin Clarity? What the Evidence Really Shows A claim circulating on Pinterest suggests that fenugreek seeds can make your skin clearer. But does the science back this up? The answer is nuanced. While fenugreek seeds are nutrient-rich and linked
- Reimagining IBD Therapy Through the Lens of Evolutionary Medicinehttps://reachmd.com/news/reimagining-ibd-therapy-through-the-lens-of-evolutionary-medicine/2468686/Emerging research highlights how evolutionary medicine—a field that examines how evolutionary processes influence health and disease—could offer novel treatment strategies for chronic inflammatory bowel diseases (IBD). By uncovering how gut bacteria adapt to inflammation, scientists aim to develo
- Use of Biologic Therapies Surpasses Conventional Treatments in Juvenile Idiopathic Arthritishttps://reachmd.com/news/use-of-biologic-therapies-surpasses-conventional-treatments-in-juvenile-idiopathic-arthritis/2468689/Juvenile idiopathic arthritis (JIA), the most common childhood rheumatic disorder, is experiencing a significant shift in treatment approaches. Over the past two decades, biologic and targeted therapies have become more prevalent, surpassing traditional treatments. A Rutgers Health study, publish
- Inebilizumab Significantly Reduces Disease Flares in Patients With IgG4-Related Diseasehttps://reachmd.com/news/inebilizumab-significantly-reduces-disease-flares-in-patients-with-igg4-related-disease/2468691/A groundbreaking phase 3 clinical trial led by Mass General Brigham has identified inebilizumab as a promising treatment for immunoglobulin G4-related disease (IgG4-RD), a rare but debilitating condition. Published in the New England Journal of Medicine, the study revealed that inebilizu